GlaxoSmithKline (GSK) Posts Improved Q4 EPS of 32.6p; Revs Ease

February 6, 2013 7:21 AM EST Send to a Friend
Get Alerts GSK Hot Sheet
Trade GSK Now!
Join SI Premium – FREE
GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of 32.6p, versus 31.2p reported last year. Revenue for the quarter came in at GBP6.8 billion, versus GBP6.98 billion reported last year.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment